MBXBF (Microbix Biosystems) Tariff Resilience Score: 5/10 (As of Jul. 01, 2026)


MBXBF Microbix Biosystems Inc MBXBF
53 GF Score
Price $0.22
GF Value $0.17
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Tariff Resilience Score?

Microbix Biosystems MBXBF +6.14% 53 Tariff Resilience Score is 5 as of Jul. 01, 2026. GuruFocus rates MBXBF with a GF Score™ of 53/100 and a GF Value™ of $0.17 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 1,374 Biotechnology companies, Microbix Biosystems ranks better than 62.23% on this metric.

Microbix Biosystems has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Microbix Biosystems has Microbix Biosystems exports a significant portion of its products, making it moderately vulnerable to tariffs. It has been affected by past tariff changes but has some ability to shift production and adjust pricing.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Microbix Biosystems might have Average Resilient.

Microbix Biosystems  (OTCPK:MBXBF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Microbix Biosystems Tariff Resilience Score Related Terms

MBXBF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Microbix Biosystems's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbix Biosystems Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Tariff Resilience Score falls into.


MBXBF
53GF Score
Microbix Biosystems Inc MBXBF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Microbix Biosystems (MBXBF) has a Tariff Resilience Score of 5 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Microbix Biosystems ranks #519 out of 1374 companies in the Biotechnology industry, placing it in the top 37.8%.
Is Microbix Biosystems' Tariff Resilience Score too high?
Microbix Biosystems' current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Microbix Biosystems' value of 5 is 25% above this industry median. Based on the distribution chart, Microbix Biosystems ranks #519 out of 1374 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Microbix Biosystems has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Microbix Biosystems ranks #519 out of 1374 companies for Tariff Resilience Score. This puts Microbix Biosystems in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Microbix Biosystems' value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Microbix Biosystems's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Microbix Biosystems's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.17, compared to a current price of $0.22 — trading 27% above its estimated fair value. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Microbix Biosystems' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Tariff Resilience Score is 5 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.22 is trading 27% above its estimated GF Value™ of $0.17. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Tariff Resilience Score: 5
  • GF Value™: $0.17 vs. price of $0.22 (27% above fair value)
  • GF Score™: 53/100 with 8 warning signs
  • Industry Position: 25% above the Biotechnology median (#519 of 1374)

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
53GF Score

Get the complete analysis for MBXBF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$0.17
GF Value